ClinicalTrials.Veeva

Menu

Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients

P

Peking University

Status

Enrolling

Conditions

Prediction Model

Study type

Observational

Funder types

Other

Identifiers

NCT06597838
2023[069-001]

Details and patient eligibility

About

Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countries has been published. We developed a simple, real-time, interpretable AKI prediction model for general hospitalized patients from a large tertiary hospital in China, and validated it across five independent, geographically distinct, different tiered hospitals.

Full description

Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countries has been published. We developed a simple, real-time, interpretable AKI prediction model for general hospitalized patients from a large tertiary hospital in China using the machine learning technique, and then validated the performance of the prediction model across five independent, geographically distinct, different tiered hospitals in China.

Enrollment

161,876 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (18 years and older) admitted to five hospitals during the study period

Exclusion criteria

  • Have less than 2 documented serum creatinine (Scr) measurements during hospitalization
  • Being diagnosed with end-stage renal disease (ESRD)
  • Maintained on dialysis or had an initial Scr greater than or equal to 4.0 mg/dL at admission
  • Developed AKI prior to admission or within 24 hours after admission
  • Length of stay shorter than 24 hours
  • Underwent kidney transplantation or nephrectomy during hospitalization
  • With all Scr measurements lower than or equal to 0.6 mg/dL from 90 days prior to admission until discharge.

Trial contacts and locations

1

Loading...

Central trial contact

Yuhui Zhang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems